PRESS RELEASE: NeoPancONE Clinical Trial Launch

PRESS RELEASE: NeoPancONE Clinical Trial Launch

Pancreatic Cancer Clinical Trial Launches During Pandemic With Aim to Change Standard of Care for Patients TORONTO, ON, July 15, 2020 – Pancreatic Cancer Canada announced today the launch of NeoPancONE, a Phase II clinical trial that aims to be a curative strategy for...